Theriva Biologics Inc. (TOVX)
1.29
-0.04 (-3.01%)
At close: Mar 04, 2025, 11:55 AM
Theriva Biologics Forecast
Stock Price Forecast
The 1 analysts with 12-month price forecasts for TOVX stock have an median target of 6, with a low estimate of 6 and a high estimate of 6. The median target predicts an increase of 365.12% from the current stock price of 1.29.
AI Analyst Report
According to 1 stock analyst, the rating for Theriva Biologics Inc. is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.
Financial Forecast this Year
Revenue This Year
21.75M
from 0
Increased by -%
Revenue Next Year
0
from 21.75M
Increased by -100%
EPS This Year
-24.11
from -28.49
Increased by 15.4%
EPS Next Year
-9.62
from -24.11
Increased by 60.1%